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Introduction
For thousands of years, humans have used selective breeding 
to improve desirable traits in both livestock and companion ani-
mals. In livestock, targeted breeding has been common practice 
since the British Agricultural Revolution of the 18th century, with 
measurable production traits such as feed conversion in cattle or 
wool production in sheep actively selected for. In the late 20th 
century, genomic selection was added to the livestock breeding 
tool box; by reading specific locations in the genome and as-
signing them to measurable production traits, faster improvement 
in livestock production efficiency has been achieved. One of 
the inherently difficult production traits to measure is resist-
ance to a specific disease, as animals with less severe symptoms 
or pathology may simply have been exposed to less pathogen. 
Experimental infections guaranteeing equal pathogen exposures 
are expensive and require large numbers of animals for genetic 
association studies, making them ethically questionable. Genome 
editing offers new opportunities to livestock breeding for disease 
resistance, allowing the direct translation of laboratory research 
into disease-resistant or resilient animals.
How Are Genome-Edited Pigs and Chicken 
Made?
Genome editors are custom enzymes that allow scientists 
to cut the DNA strands in the nucleus of a cell at a specific 
position. The researcher can then influence how the DNA is re-
paired, introducing very precise genetic changes at a target locus 
in their species of interest. This technology has been revolu-
tionary and provides exciting possibilities for the production of 
livestock resistant to viral diseases. Such opportunities are par-
ticularly pertinent given state efforts to improve global food se-
curity and reduce food waste throughout the production chain.
The most prominent editor technology today, CRISPR/Cas, 
uses a 20 nucleotide RNA guide to target its enzyme compo-
nent to a designated locus in the genome. The probability of 
off-target cutting with a high fidelity Cas enzyme is very low, 
because with four potential base combinations at each of the 
20 nucleotides there are over one trillion unique guide com-
binations. Once the enzyme has cut the DNA strands, the pre-
dominant repair pathway in most cells is nonhomologous end 
joining, an error-prone process which often introduces small 
insertions or deletions into the genetic code at the break site. 
If  the target is within a gene, such perturbations can result in 
a disruption to the function of that gene, potentially leading 
to a loss of protein function. This can be very useful to basic 
science as it allows researchers to discover functions associated 
with novel genes. For many applications, a more precise change 
to the genome is required. To that end, scientists regularly make 
an alternative DNA repair process called homology-directed 
repair. To do this, researchers provide a novel DNA sequence 
alongside the CRISPR/Cas reagents, whereby the cellular re-
pair machinery uses the new DNA as a template when fixing 
the break. This approach facilitates the introduction of defined 
Implications
• Genome editing technology enlarges the tool box of 
trait-selective breeding.
• Methods for genome editing have developed over the 
past decades, making the technology more efficient and 
specific.
• Technology to generate edited pigs and chickens is 
developing alongside genome editors to generate ani-
mals faster and more affordable.
• For two major pig diseases, it has been shown that re-
sistant animals can be generated that are refractory to 
infection. In chickens there are promising laboratory 
results but no genome-edited, resistant chickens yet.
• Genome editing allows us to overcome bottlenecks in 
trait-selective breeding and allows the incorporation of 
genetic traits from other breeds, related species, or la-
boratory results.
• Two major hurdles still to be faced prior to the imple-
mentation of this promising technology are consumer 
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changes at the genomic target locus and has sufficient refine-
ment to alter a single nucleotide, allowing precise modifica-
tion of gene function. Finally, by introducing a pair of editors, 
it is possible to generate two concurrent DNA breaks on the 
same chromosome. The cellular repair machinery then joins the 
ends of the cut sites, promoting the deletion of the intervening 
sequence. All the editor reagents introduced to the cell are rap-
idly degraded, with only the alteration to the genomic sequence 
remaining to be propagated following cell division.
Genome editing has been applied to a wide variety of agri-
cultural species including salmonids, poultry, and ruminants. 
However, due to its global economic value, relatively short gen-
eration time, and multiparous nature, the most edited livestock 
species to date is the pig. There are two main methods widely 
used for the generation of edited pigs: cloning of edited fibro-
blasts or direct injection of the zygotes with editor reagents. Both 
work well, and each has specific advantages. In cloning, fibroblast 
cells can be maintained in the lab for prolonged periods. This al-
lows researchers to introduce editor reagents into the cultured 
cells typically by lipofection, electroporation, or microinjection. 
Editing events in each cell of a population can be characterized 
and individual cells with the desired alteration to their genome 
selected for the cloning process, whereby the fibroblast cell is 
fused with an enucleated oocyte shell in a process called somatic 
cell nuclear transfer (Figure 1A). The reconstituted “zygote” is 
then transferred to a recipient gilt or sow (Carlson et al., 2012). 
Despite the benefit of being able to prescreen the donor cells, 
cloning is generally inefficient with hundreds of reconstituted 
zygotes being transferred to a single recipient. Cloning also yields 
reduced litter sizes when compared with standard breeding and 
offspring often demonstrate reduced viability.
As an alternative to cloning, newly fertilized zygotes can be 
directly microinjected with genome-editing reagents and trans-
ferred immediately back to the oviduct of a recipient animal 
(Figure 1B). In contrast to cloning, this approach (Lillico et 
al., 2013) results in the efficient establishment of pregnancies 
and robust litters. However, without the prescreening of cells 
that is routine in cloning, offspring from direct zygote manipu-
lation inevitably encompasses a range of editing outcomes, 
since selection of a specific edit is not possible. Porcine zyg-
otes can also be generated by maturation of oocytes extracted 
from slaughterhouse-derived ovaries and in vitro fertilization. 
Unfortunately, in vitro fertilization in pigs often results in 
polyspermy, rendering the resulting embryo inviable. However, 
in this controlled environment, editing rates can be increased 
and costs and animal use reduced.
An emerging alternative to these proven methods could be 
the use of surrogate sires. As a first step towards this goal, pigs 
have been edited to remove a gene required for male fertility, 
generating an empty spermatagonial stem cell niche in the 
testis (Park et al., 2017). Spermatogonial stem cells can be iso-
lated and cultured in vitro, opening the possibility to edit and 
characterize these cells before transfer to a recipient (Park et 
al., 2019) (Figure 1C).
Genetic modification of poultry poses unique challenges 
due to the very different physiology of the avian egg compared 
with a mammalian oocyte. As a result, isolation and transfer 
of a chicken yolk is not practical. One approach that has been 
taken is in ovo electroporation of editing reagents, which al-
lowed the analysis of gene function in the neural crest (Gandhi 
et al., 2017). However, others reported that electroporation re-
sulted in mosaicism with editing limited to a subset of cells as 
the chicken embryo is already much further developed when 
an egg is laid compared with a zygote (Veron et al., 2015) 
(Figure 1D). As a result, it is unlikely that this approach could 
be efficiently utilized to generate edited birds. An alternative 
approach involves sperm transfection–assisted gene editing, 
whereby sperm are lipofected with editing reagents before use 
in artificial insemination (Cooper et al., 2017) (Figure 1E). 
However, advances in chicken stem cell technology show the 
greatest promise for genome editing in chicken. Primordial 
germ cells (stem cells that eventually develop into germ cells) 
can be isolated from the blood of developing chicks in ovo 
and cultured in vitro. As with mammalian fibroblasts, these 
cells can be edited and selected in vitro before transfer into the 
bloodstream of a stage-matched recipient where they migrate 
to and populate the developing gonad. The chicken embryo is 
accessed through an opening in the egg shell, which is sealed 
again until the chicken hatches. Genome editing in primordial 
germ cells has been successfully demonstrated by a number of 
groups (Park et al., 2014; Taylor et al., 2017; Idoko-Akoh et al., 
2018) and one group has generated modified birds (Park et al., 
2014). The founder birds generated from this editing method 
are chimeric due to the presence of preexisting germ cells. The 
resulting offspring generated from breeding with the founders 
will be a mixture of edited or nonedited. Recipient chicken em-
bryos devoid of germ cells are currently being developed that 
will significantly increase the efficiency of this process (M. 
McGrew, unpublished results) (Figure 1F).
Genome editors will undoubtedly have a significant role on 
the generation of disease-resistant animals as exemplified below. 
It is important to note that currently the technology is limited 
to modifying a single gene or a SNP with large effects; however, 
disease resistance in many cases is likely to be a polygenic trait. 
Multiplexing technology is under development such that in the 
future polygenic traits could be altered in a single step.
For Which Diseases Has Genome Editing Shown 
Progress So Far?
Pigs
Porcine reproductive and respiratory syndrome 
virus. Porcine reproductive and respiratory syndrome (PRRS) 
is arguably the most economically important pig disease world-
wide. The causative agent of PRRS is an arterivirus, named 
PRRS virus (PRRSV), that affects pigs of all ages but most 
importantly causes late-term abortions and stillbirth in sows 
and severe respiratory disease in piglets with severe morbidity 
and high mortality. PRRSV also incapacitates the pig’s im-
mune response, providing an ideal breeding ground for se-
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Figure 1. Methods to generate genome-edited pigs and chickens. (A–C) Editing in pigs. (A) Somatic cell nuclear transfer or more commonly known as cloning. 
Genome editing is performed in fibroblast cells, which are cultivated in vitro. A specific edit can be selected for before transfer of the nucleus into an enu-
cleated oocyte before transfer to a recipient gilt or sow. (B) Ex vivo ovary (often slaughterhouse-derived) derived oocytes are fertilized in vitro to yield zyg-
otes for editing or zygotes harvested from donor gilts or sows. Genome editing reagents are microinjected into the zygotes and transferred to a recipient. (C) 
Spermatogonial stem cells are isolated, cultivated, and edited in vitro prior to transfer to a surrogate sire. Heterozygous offspring often need to be mated before 
yielding a resistant pig. (D–F) Editing in chickens. (D) Electroporation in ovo. Genome editing reagents are electroporated into the embryo in ovo. Resulting 
chickens are often mosaic and breeding of resistant chickens is only possible if  the germ cells are edited. (E) Editing of sperm by lipofection or electroporation 
can generate heterozygous offspring following artificial insemination. They often have to be mated to yield, homozygous chickens. (F) Primordial germ cells are 
isolated from embryos, cultivated, and edited in vitro. Selected edited cells are transferred to the blood stream of an embryo where they migrate to the gonad 
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increased use of antibiotics. PRRSV exclusively infects cells 
of the monocyte/macrophage lineage and two macrophage-
specific proteins, CD163 and CD169, were identified as recep-
tors for the virus: CD169 acting on the surface of the cells and 
CD163 inside the internalizing transport vesicles (Calvert et al., 
2007; Van Gorp et al., 2008). The virus was thought to attach 
to CD169 to be taken up into the cells; however, genome-edited 
pigs lacking CD169 were not resistant to PRRSV infection 
(Prather et al., 2013). CD163 on the other hand is thought to 
act through a key-lock interaction with the virus to allow it to 
escape from the internalizing transport vehicles into the cytosol 
where it replicates. CD163 consists of nine globular domains, 
organized like beads on a string, with domain 5 determined to 
mediate the key-lock interaction allowing viral entry into pig 
cells (Van Gorp et al., 2010). Using genome editing to generate 
pigs lacking CD163 Whitworth et al. showed for the first time 
that this approach could be used to produce livestock resistant 
to important viral diseases, in this case PRRS (Whitworth et 
al., 2016). CD163 is known to have a range of important bio-
logical functions in homeostasis, inflammation, and immune 
responses. As a refinement on functional knock out of the en-
tire CD163 protein, editing reagents were designed to remove 
only domain 5 leaving the remainder of the protein intact. 
The resulting animals were completely resistant to PRRSV 
infection and maintained the biological functions associated 
with the remaining domains of CD163 (Burkard et al., 2017; 
Burkard et al., 2018).
Porcine epidemic diarrhea virus/transmissible gastro-
enteritis virus. The two coronaviruses porcine epidemic diar-
rhea virus (PEDV) and transmissible gastroenteritis virus 
(TGEV) both cause severe diarrhea in preweaned piglets and 
are associated with high morbidity and mortality. In vitro 
host–pathogen studies identified aminopeptidase N as the re-
ceptor for TGEV and a potential receptor for PEDV (Delmas 
et al., 1992; Li et al., 2007). The use of genome editing to gen-
erate pigs lacking aminopeptidase N successfully showed that 
pigs resistant to TGEV infection could be generated. However, 
the edited animals remained susceptible to PEDV infection 
(Whitworth et al., 2019). Aminopeptidase N is important for 
peptide digestion in the small intestine and knockout mice 
were shown to have delayed mammary gland development. 
In humans, aminopeptidase N defects are associated with dif-
ferent types of leukemia and lymphoma. Therefore, further 
investigation into the potential consequences of the absence 
aminopeptidase N in pigs is warranted as it may affect the 
overall health and/or productivity of the animals.
African swine fever virus. African swine fever virus (ASFV) 
causes a severe hemorrhagic disease in domestic pigs (Sus scrofa 
domesticus) and wild boars (Sus scrofa ferus) with high mor-
tality in pigs of all ages. ASFV is highly contagious and can be 
transmitted by soft ticks of the Ornithodoros genus. It was iden-
tified in and contained to Africa with occasional transmission 
around the Strait of Gibraltar into Portugal and Spain. In 2007 
an introduction of the virus into the Caucasus region showed 
that the virus does not solely rely on ticks for transmission in 
the wild, as transport of contaminated material and direct con-
tact between animals have been shown to be major routes of 
disease dissemination. Since then, the virus has spread across 
Eastern Europe and Russia and was recently found in Western 
Europe and China. ASFV poses a huge risk to the pig industry 
worldwide and is a limiting factor to a sustainable pig industry 
in many parts of Africa. Interestingly, ASFV also infects wild 
suids, such as warthogs (Phacocherus africanus) and bushpigs 
(Potamocherus porcus), without causing overt disease. Such in-
fected wild suids are thought to act as a reservoir of the virus in 
Africa. In the late stages of ASFV infection, a cytokine storm, 
i.e., an overreaction of the immune system, is observed, which is 
thought to strongly contribute to the lethal outcome of disease. 
A comparison of the warthog and domestic pig genomes iden-
tified differences in the Rel-like domain-containing protein A 
(RELA, also known as p65) protein, which is involved in NF-κb 
cytokine signaling, was thought to underlie the different re-
sponses of the related species to ASFV infection (Palgrave et al., 
2011). Researchers used genome editing to convert a key region 
of the encoded domestic pig protein sequence to the warthog 
equivalent (Lillico et al., 2016). Data on susceptibility of the 
edited animals to ASFV infection have yet to be reported. In 
this instance, it is important to differentiate between disease re-
sistance, the ability of an animal to suppress the establishment 
and/or development of an infection, and disease resilience, 
where an infected host manages to maintain an acceptable level 
of productivity despite challenge pressure. Should these pigs 
prove to be resilient to ASFV infection it is likely that their use 
may not be permitted in many jurisdictions, since they could act 
as reservoirs of infection. However, in environments where the 
disease is endemic use of such animals could be beneficial.
Chicken
Avian leucosis virus. Avian leukosis virus infection results in 
inappetence, diarrhea, weight loss, a reduction in eggs laid, and 
often causes tumor formation in the chicken. The virus is div-
ided into six subgroups, with the avian leucosis virus subgroup 
J (ALV-J) shown to be responsible for major disease outbreaks 
in China. The cellular receptor of ALV-J was identified to be 
the chicken sodium/hydrogen exchanger 1 protein on the cell 
surface. Chicken somatic cell lines have been edited to intro-
duce changes to this gene-conferring resistance to avian leu-
cosis virus in vitro (Lee et al., 2017). Despite cells showing 
resistance to ALV-J infection, no edited chickens have been 
produced to date. In both mice and humans, a lack of the so-
dium/hydrogen exchanger 1 protein is associated with severe 
neurological disease; however, targeted changes to single amino 
acids may retain biological functions of the protein in chicken 
while resulting in disease resistance.
Avian influenza virus. In chickens, disease resistance to avian 
influenza is at the top of the wish list due to the serious impact 
on chicken health but also the risk of transmission to humans. 
Similarly, influenza A is also one of the diseases on the resistance 
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virus adaptation to humans. The acidic leucine-rich nuclear 
phosphoprotein-32A (ANP32A) was found to play a key role 
in avian influenza virus replication in both chicken and water 
fowl. Although the virus polymerase protein readily interacts 
with the avian ANP32A, the human version of the same protein 
supports only limited replication of the viral genome. It has been 
demonstrated in vitro that deletion of a small region of chicken 
ANP32A can prevent replication of avian influenza virus (Long 
et al., 2016; Long et al., 2019). Although the functional conse-
quence of edited ANP32A has yet to be demonstrated in vivo, 
such approaches offer exciting opportunities that have the poten-
tial to benefit both industry and animal welfare.
As exemplified above, currently many gene editing ap-
proaches focus on targeting host genes involved in mediating 
entry of the virus, with a special focus on receptors. However, 
as the example for avian influenza shows, host genes play an 
important role in other steps of the pathogen replication cycle 
and also provide editing targets for disease resilience or re-
sistance. More in-depth host–pathogen interaction studies, 
including genome-wide editing studies in vitro, will no doubt 
produce a variety of further candidate genes for genetic disease 
resistance.
An alternative antipathogen approach pursued for decades 
is the generation of transgenic livestock, expressing antiviral 
or antibacterial agents, such as enzymes or small interfering 
RNAs. Genome editing can be used to improve the integra-
tion efficiency of these transgenes at specific locations in the 
genome; however, the discussion of transgenic disease-resistant 
animals is beyond the scope of this review.
How does genome editing fit within existing se-
lective breeding structures and how will it be 
regulated?
Selective breeding has generated highly productive, robust 
animals that are adapted to a modern production environment. 
Livestock production is dynamic, with evolving challenges 
such as climate change and disease outbreaks coupled with so-
cietal pressure to reduce antimicrobial use. Selective breeding 
for disease resistance has proven difficult, as outbreaks are 
often sporadic and resistant/resilient animals often difficult to 
identify. In circumstances where a genetic trait for disease re-
sistance can be identified in the breeding population, then se-
lection through the selective breeding can be achieved. A good 
example of  this is pigs with resistance to F18 type enterotoxi-
genic E. coli. Association studies revealed that a polymorphism 
in the fucosyl transferase 1 gene conferred resistance to these 
bacteria. There was initial concern that selection for the locus 
Figure 2. Genetic resistance to disease and how genome editing can help integrate traits into highly productive lines. (A) Genetic resistance to disease may be 
present in a small percentage of production animals and genetic selection for these animals may be associated with the risk of inbreeding, productivity loss, or 
the risk of losing other desirable traits. Genome editing allows integration of the disease-resistance trait into a wider selection of pigs, ensuring genetic vari-
ability and maintenance of desirable traits. (B) Genetic resistance to disease may be present in an indigenous or less productive breed. Crossbreeding would 
result in productivity loss and the risk of losing other desirable traits, such as fur color. Genome editing allows for incorporation of genetic disease resistance 
into highly bred lines without losing productivity. (C) Genetic resistance may be observed in a closely related species, e.g., wild boar or wild suids in the case of 
the domestic pig. Integration into highly bred domestic pig lines would only be possible by genome editing. (D) Resistance genes may be identified in laboratory 
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harboring this gene may counterselect for another gene associ-
ated with stress resistance. However, this proved not to be the 
case and genetic selection for the favorable fucosyl transferase 
1 allele has been integrated into many pig-breeding programs 
(Coddens et al., 2008). This was possible, in part, because the 
favorable allele was present at sufficient prevalence (in most 
studies between 5% and 10%) in the breeding population to 
allow for selection while avoiding inbreeding. In circumstances 
where an allelic variant associated with a resistant phenotype 
is present at a much lower frequency, it may prove difficult to 
incorporate effective selection into a standard breeding regime 
without the risk of  inbreeding and related longer-term prod-
uctivity loss (Figure 2A). Genome editing has the potential to 
contribute in such circumstances, allowing the direct introgres-
sion of  a beneficial allele into the offspring of  diverse, highly 
productive animals. Similarly, disease-resistance traits asso-
ciated with less productive indigenous breeds are unlikely to 
be introduced to highly productive populations by standard 
crossbreeding as this would result in a significant set-back 
in productivity, abrogating decades or even centuries of  ad-
vances made through genetic selection (Figure 2B). In circum-
stances where resistance or resilience is observed in a related 
species, crossbreeding is simply not possible. Genome editing 
could bridge these gaps. One example of  this is resilience of 
wild suids to African swine fever virus while domestic pigs 
can suffer from severe disease. It is not possible to crossbreed 
these species, so introduction of  the genetics underlying re-
silience is not possible by this route. Genetic comparison can 
be used to identify the functional differences underlying such 
traits, and genome editing employed to introduce appropriate 
variants into domestic pigs (Figure 2C). Finally, with a good 
understanding of  host–pathogen interactions, novel genetics 
that has not been observed in live animals can be created and 
tested for efficacy in a laboratory environment. This was the 
case for both the CD163/PRRSV and APN/TGEV examples 
in pigs and would be the case for the ANP32A/ influenza and 
the ALV-J resistance in chicken, described above. In such cir-
cumstances, integration through genome editing presents a 
practical route to benefit from the findings (Figure 2D). It is 
imperative that in such circumstances thorough phenotypic 
characterization of  the edited animals be carried out as de-
letion of  all or part of  a functional protein could result in 
a loss of  (systemic) biological function. A second measure 
worthy of  consideration before embarking on an editing pro-
ject is whether the gene is located within a locus that has been 
actively selected in breeding programs. This could indicate 
whether a potential target is associated with known produc-
tion traits. This approach has been taken for PRRSV-resistant 
pigs, with evaluation as to whether the CD163 gene locus has 
been selected for in pig breeding programs (Johnsson et al., 
2018).
Conclusions
Overall, genome editing holds vast promise for the fu-
ture production of animals resistant or resilient to disease, 
improving productivity and animal welfare while reducing food 
waste throughout the production chain. Through reduction of 
primary and secondary infections, it should also be possible 
to reduce antimicrobial use in livestock production. Technical 
improvements in the generation of genome editing animals will 
undoubtedly reduce the cost implications of this technology. 
The two major hurdles still to be faced prior to implementa-
tion of this promising technology are consumer acceptance 
and the regulatory framework. Approval of edited animals for 
human consumption relies on national and multinational legis-
lation, which is currently at early stages. Encouragingly, some 
international jurisdictions such as Argentina and Brazil have 
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